{"id":"NCT01878812","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older","officialTitle":"Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine (GSK2321138A) Fluarix/Influsplit Tetra® (2013/2014 Season) in Adults 18 Years of Age and Older","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07-11","primaryCompletion":"2013-08-05","completion":"2013-08-05","firstPosted":"2013-06-17","resultsPosted":"2015-01-12","lastUpdate":"2018-09-07"},"enrollment":117,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Fluarix/Influsplit Tetra® (2013-2014 season)","otherNames":[]}],"arms":[{"label":"Fluarix/Influsplit Tetra® Adult Group","type":"EXPERIMENTAL"},{"label":"Fluarix/Influsplit Tetra® Elderly Group","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to assess, in adults 18 years of age and above, the immunogenicity and reactogenicity of the seasonal influenza vaccine, Fluarix/Influsplit Tetra containing the four influenza strains (two A strains and two B strains) for the 2013/2014 season.","primaryOutcome":{"measure":"Anti-HI Antibody Titers Against 4 Strains of Influenza Disease","timeFrame":"At Days 0 and 21","effectByArm":[{"arm":"Fluarix/Influsplit Tetra® Adult Group","deltaMin":29.8,"sd":null},{"arm":"Fluarix/Influsplit Tetra® Elderly Group","deltaMin":14.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":19},"locations":{"siteCount":4,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":["https://clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":60},"commonTop":["Pain","Myalgia","Fatigue","Headache","Induration"]}}